Inotiv, Inc. Stock: price and insider trades · United States

Inotiv, Inc. is a U.S.-based company listed on the NASDAQ in the United States, and it operates as a contract research organization (CRO) focused on preclinical drug discovery and development support. Based on the company’s investor materials and latest annual filing, Inotiv provides nonclinical and analytical services to help pharmaceutical, biotechnology, medical device, academic, and government customers move programs through discovery and preclinical development, and in some cases into early clinical support. The company is headquartered in West Lafayette, Indiana, and traces its operating history back to 1975, when it began as Bioanalytical Systems, Inc.; it adopted the Inotiv name in March 2021.

Inotiv’s business is organized into two reportable segments. Discovery and Safety Assessment (DSA) covers discovery and translational sciences, safety assessment, toxicology, pathology, analytical chemistry, surgery, and related preclinical services. Research Models and Services (RMS) supplies purpose-bred animal research models, specialized disease models, and associated products such as diets, bedding, and enrichment items. This gives Inotiv a hybrid profile: one part scientific services provider, one part research-model supplier. That structure can be attractive to customers seeking an integrated preclinical partner, while also making the business sensitive to pharma and biotech R&D spending cycles, utilization trends, and regulatory standards governing animal research and nonclinical studies.